These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32061816)

  • 1. Recurrence of urinary tract infections with extended-spectrum β-lactamase-producing Escherichia coli caused by homologous strains among which clone ST131-O25b is dominant.
    Karami N; Lindblom A; Yazdanshenas S; Lindén V; Åhrén C
    J Glob Antimicrob Resist; 2020 Sep; 22():126-132. PubMed ID: 32061816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation of Virulence Factors, Phylogenetic Group Features, and the Presence of ST131 Clone in Escherichia coli Isolates, a Urinary Tract Infection Agent in Children].
    Kılıç SG; Öcal D; Tekeli A; Dolapçı İ
    Mikrobiyol Bul; 2023 Oct; 57(4):535-552. PubMed ID: 37885384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology of Escherichia coli sequence type 131 and its H30/H30-Rx subclones recovered from extra-intestinal infections: first report of OXA-48 producing ST131 clone from Iran.
    Hojabri Z; Mirmohammadkhani M; Kamali F; Ghassemi K; Taghavipour S; Pajand O
    Eur J Clin Microbiol Infect Dis; 2017 Oct; 36(10):1859-1866. PubMed ID: 28550370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli.
    Can F; Kurt-Azap Ö; İspir P; Nurtop E; Seref C; Loçlar İ; Aktaş ON; Orhan YC; Ergonul O
    J Glob Antimicrob Resist; 2016 Mar; 4():49-52. PubMed ID: 27436393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M; Alonso MP; Nicolas-Chanoine MH; Dahbi G; Mora A; Blanco JE; López C; Cortés P; Llagostera M; Leflon-Guibout V; Puentes B; Mamani R; Herrera A; Coira MA; García-Garrote F; Pita JM; Blanco J
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and molecular features of sequence type (ST) 131 extended-Spectrum-β-lactamase-producing Escherichia coli in community-onset female genital tract infections.
    Kim YA; Lee K; Chung JE
    BMC Infect Dis; 2018 Jun; 18(1):250. PubMed ID: 29859045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Quinolone Resistance of Extended-Spectrum β-Lactamase-Producing
    Teramae M; Osawa K; Shigemura K; Kitagawa K; Shirakawa T; Fujisawa M; Miyara T
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of MLVA for epidemiological typing and outbreak detection of ESBL-producing Escherichia coli in Sweden.
    Helldal L; Karami N; Welinder-Olsson C; Moore ER; Åhren C
    BMC Microbiol; 2017 Jan; 17(1):8. PubMed ID: 28061803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Report of Prevalence of CTX-M-15-Producing Escherichia coli O25b/ST131 from Iran.
    Namaei MH; Yousefi M; Ziaee M; Salehabadi A; Ghannadkafi M; Amini E; Askari P
    Microb Drug Resist; 2017 Oct; 23(7):879-884. PubMed ID: 28437226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.
    Price LB; Johnson JR; Aziz M; Clabots C; Johnston B; Tchesnokova V; Nordstrom L; Billig M; Chattopadhyay S; Stegger M; Andersen PS; Pearson T; Riddell K; Rogers P; Scholes D; Kahl B; Keim P; Sokurenko EV
    mBio; 2013 Dec; 4(6):e00377-13. PubMed ID: 24345742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan.
    Matsumura Y; Yamamoto M; Nagao M; Hotta G; Matsushima A; Ito Y; Takakura S; Ichiyama S;
    J Antimicrob Chemother; 2012 Nov; 67(11):2612-20. PubMed ID: 22843833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the ST131 clone on recurrent ESBL-producing E. coli urinary tract infection: a prospective comparative study.
    Lindblom A; Kiszakiewicz C; Kristiansson E; Yazdanshenas S; Kamenska N; Karami N; Åhrén C
    Sci Rep; 2022 Jun; 12(1):10048. PubMed ID: 35710924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of extended spectrum-β-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants.
    Cheng MF; Chen WL; Hung WY; Huang IF; Chiou YH; Chen YS; Lee SS; Hung CH; Wang JL
    Pediatr Infect Dis J; 2015 May; 34(5):469-75. PubMed ID: 25879646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence and spread of O16-ST131 and O25b-ST131 clones among faecal CTX-M-producing Escherichia coli in healthy individuals in Hunan Province, China.
    Zhong YM; Liu WE; Liang XH; Li YM; Jian ZJ; Hawkey PM
    J Antimicrob Chemother; 2015 Aug; 70(8):2223-7. PubMed ID: 25957581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended-spectrum β-lactamase-producing Escherichia coli isolated from healthy humans in Mexico, including subclone ST131-B2-O25:H4-H30-Rx.
    Cortés-Cortés G; Lozano-Zarain P; Torres C; Alonso CA; Ríos-Torres AM; Castañeda M; López-Pliego L; Navarro A; Del Carmen Rocha-Gracia R
    J Glob Antimicrob Resist; 2017 Jun; 9():130-134. PubMed ID: 28552831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.
    Matsumura Y; Nagao M; Iguchi M; Yagi T; Komori T; Fujita N; Yamamoto M; Matsushima A; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2013 Feb; 19(2):161-8. PubMed ID: 22332968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of O25b-ST131 clone among Escherichia coli strains producing CTX-M-15, CTX-M-14 and CTX-M-92 β-lactamases.
    Giedraitienė A; Vitkauskienė A; Pavilonis A; Patamsytė V; Genel N; Decre D; Arlet G
    Infect Dis (Lond); 2017 Feb; 49(2):106-112. PubMed ID: 27563748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.
    Sherchan JB; Hayakawa K; Miyoshi-Akiyama T; Ohmagari N; Kirikae T; Nagamatsu M; Tojo M; Ohara H; Sherchand JB; Tandukar S
    Antimicrob Agents Chemother; 2015; 59(6):3424-32. PubMed ID: 25824221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive Household Outbreak of Urinary Tract Infection and Intestinal Colonization due to Extended-Spectrum β-Lactamase-Producing Escherichia coli Sequence Type 131.
    Madigan T; Johnson JR; Clabots C; Johnston BD; Porter SB; Slater BS; Banerjee R
    Clin Infect Dis; 2015 Jul; 61(1):e5-12. PubMed ID: 25828998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.